Lets Talk Finances

Provoking Discussion on Personal Finance and Investing

FMS - Fresenius Medical Care AG & Co. KGaA ()

Overview

Company Summary


Fresenius Medical Care AG & Co. KGaA (FMS) is a global company primarily engaged in providing various medical services and products related to dialysis and renal care. Founded in Germany in 1996, Fresenius Medical Care has since grown to become the world's largest integrated provider of dialysis products and services.

The company's main focus lies in the treatment of chronic kidney failure, also known as end-stage renal disease (ESRD). Fresenius Medical Care operates a vast network of dialysis clinics worldwide, offering comprehensive renal care services to patients in need. These clinics provide life-sustaining dialysis treatments, which involve removing waste and excess fluids from the blood when the kidneys can no longer perform this function.

Additionally, Fresenius Medical Care manufactures and distributes a wide range of dialysis machines, consumables, and pharmaceuticals essential for dialysis procedures. They develop advanced medical technologies to enhance patient care and improve outcomes in the field of renal therapies.

Fresenius Medical Care also offers integrated care management services, providing coordinated care for ESRD patients across different healthcare settings, including hospitals, dialysis clinics, and home environments. This approach aims to optimize patient outcomes while ensuring cost-efficient and high-quality care.

Furthermore, the company engages in research and development activities to advance the understanding and treatment of kidney diseases. Fresenius Medical Care collaborates with leading medical institutions and experts to develop innovative solutions, improve dialysis techniques, and establish preventive measures for kidney-related conditions.

In summary, Fresenius Medical Care AG & Co. KGaA is a global leader in dialysis and renal care. They provide comprehensive dialysis services, manufacture and distribute dialysis products, and drive research and development efforts to enhance the treatment of kidney diseases.

Notes (see all)

News